Skip to main content

Table 1 Description of the data set in terms of studies per treatment and the sample sizes, on day 28

From: Comparison of anti-malarial drug efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis

Treatments

Studies per treatment arm

Studies tested the trt with AL

Total sample size

Nbr of ACPR

% of ACPR

AL

63

–

12,981

11,426

88

AQSP

12

7

2681

1731

64.56

ASAQ

42

31

8254

7402

89.6

ASAQCPH

1

1

54

47

87.03

ASATPG

1

0a

100

95

95

ASCD

4

4

1591

1326

83.3

ASMQ

6

5

843

800

94.89

ASNAPH

2

2

147

144

97.95

ASPY

2

2

1204

1105

91.77

ASSMP

4

3

1545

1461

94.5

ASSP

11

3

1752

1593

91

DHAP

22

18

6182

4969

80.3

DHAPT

1

1

212

204

96.2

  1. Data were extracted for all studies. The combination AL was the most frequently evaluated drug combination within the data. Few studies tested novel combinations. There was no study comparing ASATPG directly to AL
  2. Nbr number, trt treatment, ACPR adequate clinical and parasitological response corrected by PCR